Abstract
Dostarlimab (Jemperli (TM); GlaxoSmithKline) is a humanized monoclonal antibody programmed death-1 (PD-1) receptor antagonist being developed for the ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
